San Franciso biotech start-up Loyal has raised £115m to develop a drug to give an extra year of healthy life to dogs.
The pill mimics the metabolic effects that come with fasting, so the dog’s body operates on fewer calories and metabolises fuel more efficiently. It’s not an appetite suppressant like Ozempic; it improves metabolic fitness without affecting appetite. Ultimately, they aim to develop a human version of the drug too.
Would you be one of the first to give this to your dog? Let us know what you think here, on Facebook, or by writing to editorial@dogstodaymagazine.co.uk with “Great Debate” in the subject line.
